Literature DB >> 15711794

Construction of highly efficient E. coli expression systems containing low oxygen induced promoter and partition region.

Tao Liu1, Jing-Yu Chen, Zhong Zheng, Tian-Hong Wang, Guo-Qiang Chen.   

Abstract

A series of high-copy-number Escherichia coli expression vectors equipped with an oxygen-sensitive promoter P(vgb) of Vitreoscilla hemoglobin (encoded by the vgb gene) were constructed and characterized. Plasmid pKVp containing P(vgb) was inducible by low oxygen tension, while plasmid pKVpP containing a partition (par) region from plasmid pSC101 ligated to P(vgb) provided inheritable stability for the vectors in the absence of ampicillin. Plasmid pKVpV had the Vitreoscilla hemoglobin operon vgb ligated to P(vgb), while a construct containing P(vgb), the vgb operon and a par region constituted plasmid pKVpPV. Shake-flask studies demonstrated that plasmids pKVpV and pKVpPV expressed higher levels of Vitreoscilla hemoglobin under low aeration condition (5% air saturation in water) compared with the levels observed under strong aeration (20% air saturation in water). Introduction of either the enhanced green fluorescent protein (eGFP) gene egfp or the toluene dioxygenase (TDO) gene tod into either pKVpV (P(vgb), vgb operon) or pKVpPV (P(vgb), vgb operon, par) slightly attenuated (approximately 30%) the strong expression of VHb under low aeration. However, all displayed approximately a three-fold increase versus that observed for strong aeration. Recombinant E. coli harboring either pKVp-E (P(vgb), egfp) or pKVpP-E (P(vgb), par, egfp) displayed at least a two-fold increase in eGFP expression under conditions of low aeration and absence of antibiotic, compared with that under strong aeration after 24 h of cultivation. Strong expression of TDO was also observed using low aeration in recombinant E. coli harboring pKVpPV-T (P(vgb), vgb operon, par, tod) or pKVpP-T (P(vgb), par, tod). Plasmids containing the par region were stable over 100 generations. These results indicate that the novel expression system combining plasmid stability over the cell growth phase and a promoter inducible by low oxygen tension will be very useful for high-density production of foreign proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711794     DOI: 10.1007/s00253-005-1913-6

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  7 in total

Review 1.  Overview of regulatory strategies and molecular elements in metabolic engineering of bacteria.

Authors:  Tianwen Wang; Xingyuan Ma; Guocheng Du; Jian Chen
Journal:  Mol Biotechnol       Date:  2012-11       Impact factor: 2.695

2.  Recombinant hemoglobin II from Lucina pectinata: a large-scale method for hemeprotein expression in E. coli.

Authors:  Cacimar Ramos; Ruth Pietri; Wilmarie Lorenzo; Elddie Roman; Laura B Granell; Carmen L Cadilla; Juan López-Garriga
Journal:  Protein J       Date:  2010-02       Impact factor: 2.371

3.  Vitreoscilla hemoglobin enhances the catalytic performance of industrial oxidases in vitro.

Authors:  Qingzhuo Wang; Huabao Zheng; Rongsheng Tao; Qi Li; Yu Jiang; Sheng Yang
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-17       Impact factor: 4.813

4.  Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.

Authors:  Amir Ghaemi; Hoorieh Soleimanjahi; Pooria Gill; Zuhair Hassan; Soodeh Razeghi M Jahromi; Farzin Roohvand
Journal:  Genet Vaccines Ther       Date:  2010-05-12

Review 5.  Progress in metabolic engineering of Saccharomyces cerevisiae.

Authors:  Elke Nevoigt
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

6.  Efficient strategies to enhance plasmid stability for fermentation of recombinant Escherichia coli harboring tyrosine phenol lyase.

Authors:  Xiao-Ling Tang; Wen-Ye Hu; Zhi-Chao Wang; Ren-Chao Zheng; Yu-Guo Zheng
Journal:  Biotechnol Lett       Date:  2021-04-08       Impact factor: 2.461

7.  Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium.

Authors:  Fara A P Eguia; Daniele E Mascarelli; Eneas Carvalho; Gretel R Rodríguez; Edson Makiyama; Primavera Borelli; Celia Lieberman; Paulo Lee Ho; Giovana C Barazzone; Viviane M Gonçalves
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-17       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.